Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 33

Sort by

Sort Order Select

Journal Articles

The Prognostic Significance of Soluble Interleukin-2-Receptor, Beta-2-Microgrobulin and Serum Albumin in Patient with Diffuse Large B-Cell Lymphoma in the Rituximab Era

Norihito Inoue, MD, Masahiro Yokoyama, MD, Yuko Shirouchi, MD, Takanori Fukuta, MD, Anna Nishihara, MD, Yoshiharu Kusano, MD, Hideki Uryu, MD, Yuko Mishima, MD PhD, Noriko Nishimura, MD PhD, Naoko Tsuyama, MD PhD, Kengo Takeuchi, MD PhD, Yasuhito Terui, MD PhD

Blood (2018) 132 (Supplement 1): 4242.

https://doi.org/10.1182/blood-2018-99-115863

Published: 2018

Journal Articles

Efficacy of Rituximab Maintenance for Diffuse Large B Cell Lymphoma with Transformation

Hideki Uryu, MD, Yuko Mishima, MD PhD, Masahiro Yokoyama, MD, Noriko Nishimura, MD PhD, Yoshiharu Kusano, MD, Norihito Inoue, MD, Anna Nishihara, MD, Takanori Fukuta, MD, Yuko Shirouchi, MD, Naoko Tsuyama, MD PhD, Kengo Takeuchi, MD PhD, Yasuhito Terui, MD PhD

Blood (2018) 132 (Supplement 1): 4229.

https://doi.org/10.1182/blood-2018-99-111513

Published: 2018

Journal Articles

Impact of Creatinine Clearance in Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP : A Real-World Long-Term Observation Analysis at a Single Institute

Noriko Nishimura, MD PhD, Takanori Fukuta, MD, Anna Nishihara, MD, Yuko Shirouchi, MD, Hideki Uryu, MD, Norihito Inoue, MD, Yoshiharu Kusano, MD, Naoko Tsuyama, MD PhD, Kengo Takeuchi, MD PhD, Yuko Mishima, MD PhD, Masahiro Yokoyama, MD, Yasuhito Terui, MD PhD

Blood (2018) 132 (Supplement 1): 5399.

https://doi.org/10.1182/blood-2018-99-115897

Published: 2018

Journal Articles

B-Symptoms, Performance Status and Response to First Therapy As Survival Predictive Factors for Peripheral T-Cell Lymphoma at Progression/Relapse: A Single Institute Analysis

Yuko Shirouchi, MD, Takanori Fukuta, MD, Anna Nishihara, MD, Norihito Inoue, MD, Hideki Uryu, MD, Yoshiharu Kusano, MD, Noriko Nishimura, MD PhD, Yuko Mishima, MD PhD, Masahiro Yokoyama, MD, Naoko Tsuyama, MD PhD, Kengo Takeuchi, MD PhD, Yasuhito Terui, MD PhD

Blood (2018) 132 (Supplement 1): 5360.

https://doi.org/10.1182/blood-2018-99-112038

Published: 2018

Journal Articles

The Prognosis of Transformed DLBCL Were Superior to De Novo DLBL after the Relapsed/Refractory Status Related to the MYC Translocation

Yuko Mishima, PhD, Masahiro Yokoyama, MD, Noriko Nishimura, MD PhD, Yoshiharu Kusano, MD, Hideki Uryu, MD, Norihito Inoue, MD, Anna Nishihara, MD, Takanori Fukuta, MD, Yuko Shirouchi, MD, Naoko Tsuyama, MD PhD, Kengo Takeuchi, MD PhD, Yasuhito Terui, MD PhD

Blood (2018) 132 (Supplement 1): 5417.

https://doi.org/10.1182/blood-2018-99-111081

Published: 2018

Journal Articles

The Role of Image Surveillance in Patients with Diffuse Large B-Cell Lymphoma: A Single-Center Validation Study

Takanori Fukuta, MD, Noriko Nishimura, MD PhD, Yuko Shirouchi, MD, Anna Nishihara, MD, Norihito Inoue, MD, Hideki Uryu, MD, Yoshiharu Kusano, MD, Yuko Mishima, MD PhD, Naoko Tsuyama, MD PhD, Kengo Takeuchi, MD PhD, Masahiro Yokoyama, MD, Yasuhito Terui, MD PhD

Blood (2018) 132 (Supplement 1): 2989.

https://doi.org/10.1182/blood-2018-99-113984

Published: 2018

Journal Articles

Structural Variations Involving Programmed Death Ligands in B-Cell and T-Cell Lymphomas

Keisuke Kataoka, MD PhD, Hiroaki Miyoshi, MD PhD, Yasunori Kogure, MD, Yasuharu Sato, MD PhD, Kenji Nishida, MD, Yuichi Shiraishi, PhD, Hiroko Tanaka, BA, Kenichi Chiba, BA, Yosaku Watatani, MD, Yusuke Shiozawa, MD, Kenichi Yoshida, MD PhD, Masashi Sanada, MD PhD, Motohiro Kato, MD PhD, Satoru Miyano, PhD, Koji Izutsu, MD PhD, Kengo Takeuchi, MD PhD, Tadashi Yoshino, MD PhD, Koichi Ohshima, MD PhD, Seishi Ogawa, MD PhD

Blood (2016) 128 (22): 4105.

https://doi.org/10.1182/blood.V128.22.4105.4105

Published: 2016

Journal Articles

Absolute CD4+ T-Cell Count Predicts Survival in Diffuse Large B-Cell Lymphoma

Yoshiharu Kusano, MD, Yasuhito Terui, MD PhD, Kengo Takeuchi, MD PhD, Anna Takahashi, MD, Norihito Inoue, MD, Hirohumi Yamauchi, MD, Naoko Tsuyama, MD, Kyoko Ueda, MD, Yuko Mishima, MD PhD, Noriko Nishimura, MD PhD, Masahiro Yokoyama, MD, Kiyohiko Hatake, MDPhD

Blood (2016) 128 (22): 3053.

https://doi.org/10.1182/blood.V128.22.3053.3053

Published: 2016

Journal Articles

The Relapsed - Memorial Sloan - Kettering Cancer Center (R-MSKCC) Prognostic Score Is a Risk-Stratification Model for the Central Nervous System (CNS) Involvement at Relapse in Patients with Diffuse Large B Cell Lymphoma (DLBCL) in the Rituximab Era

Noriko Nishimura, MD PhD, Yasuhito Terui, MD PhD, Kengo Takeuchi, MD PhD, Naoko Tsuyama, MD, Anna Takahashi, MD, Norihito Inoue, MD, Hirofumi Yamauchi, MD, Yoshiharu Kusano, MD, Yuko Mishima, MD PhD, Masahiro Yokoyama, MD, Kiyohiko Hatake, MD PhD

Blood (2016) 128 (22): 4221.

https://doi.org/10.1182/blood.V128.22.4221.4221

Published: 2016

Journal Articles

The Efficacy of JAK2 Inhibitor in Heavily Pretreated Classical Hodgkin Lymphoma: A Prospective Pilot Study of Ruxolitinib in Relapsed or Refractory Classical Hodgkin Lymphoma and Primary Mediastinal Large B-Cell Lymphoma

Seok Jin Kim, MD PhD, Hye Jin Kang, MD PhD, Shin Dong-Yeop, MD PhD, Ho Sup Lee, Sung Yong Oh, MD, Ho-Jin Shin, MD PhD, Dok Hyun Yoon, Jung Yong Hong, MD, Jee Hyun Kong, Kana Sakamoto, Young Hyeh Ko, MD, Kengo Takeuchi, MD PhD, Cheolwon Suh, Won Seog Kim

Blood (2016) 128 (22): 1820.

https://doi.org/10.1182/blood.V128.22.1820.1820

Published: 2016

Journal Articles

80% Dose R-CHOP Is Suitable Chemotherapy for Very Elderly Patients with DLBCL

Anna Takahashi, MD, Yuko Mishima, MD PhD, Norihito Inoue, MD, Yoshiharu Kusano, MD, Tadahiro Gunji, MD, Kyoko Ueda, MD, Noriko Nishimura, MD PhD, Hideaki Nitta, MD PhD, Masahiro Yokoyama, MD, Naoko Tsuyama, MD, Kengo Takeuchi, MD PhD, Yasuhito Terui, MD PhD, Kiyohiko Hatake, MD PhD

Blood (2015) 126 (23): 5094.

https://doi.org/10.1182/blood.V126.23.5094.5094

Published: 2015

Journal Articles

Higher Titer of Anti-EBV Nuclear Antigen Antibodies Might be a Marker of Poorer Prognosis in Patients with Peripheral T-Cell Lymphoma, Not Otherwise Specified

Yoshiharu Kusano, MD, Yasuhito Terui, MD PhD, Kyoko Ueda, MD, Yuko Mishima, MD PhD, Noriko Nishimura, MD PhD, Masahiro Yokoyama, MD, Hideaki Nitta, MD PhD, Tadahiro Gunji, MD, Norihito Inoue, MD, Anna Takahasi, MD, Kengo Takeuchi, MD PhD, Kiyohiko Hatake, MD PhD

Blood (2015) 126 (23): 5016.

https://doi.org/10.1182/blood.V126.23.5016.5016

Published: 2015

Journal Articles

The Presence of M Protein Is Strongly Associated with Very Poor Prognosis in Patients with Extranodal Diffuse Large B-Cell Lymphoma

Hideaki Nitta, MD PhD, Yasuhito Terui, MD PhD, Masahiro Yokoyama, MD, Yuko Mishima, MD PhD, Noriko Nishimura, MD PhD, Kyoko Ueda, MD, Tadahiro Gunji, MD, Yoshiharu Kusano, MD, Norihito Inoue, MD, Anna Takahashi, MD, Naoko Tsuyama, MD, Kengo Takeuchi, MD PhD, Kiyohiko Hatake, MD PhD

Blood (2015) 126 (23): 5638.

https://doi.org/10.1182/blood.V126.23.5638.5638

Published: 2015

Journal Articles

Long-Term Survival with High-Dose Chemotherapy Followed By Autologous Stem Cell Transplantation and Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm: A Retrospective Registry Study from the Japan Society for Hematopoietic Cell Transplantation

Tomohiro Aoki, MD, Ritsuro Suzuki, Yachiyo Kuwatsuka, MDPhD, Shinichi Kako, MD, Katsuya Fujimoto, MD PhD, Jun Taguchi, MD PhD, Tadakazu Kondo, MD PhD, Akiyo Yoshida, MD, Toshiro Ito, MD PhD, Yoshimasa Kamoda, Takahiro Fukuda, MD, Tatsuo Ichinohe, Kengo Takeuchi, MD PhD, Koji Izutsu, Junji Suzumiya

Blood (2014) 124 (21): 2560.

https://doi.org/10.1182/blood.V124.21.2560.2560

Published: 2014

Journal Articles

Identification of Cell-Type-Specific Mutations in Angioimmunoblastic T-Cell Lymphoma

Tran Bich Nguyen, MD, Mamiko Sakata-Yanagimoto, MD PhD, Yukitsugu Asabe, Kenichi Yoshida, MD PhD, Hideharu Muto, MD PhD, Rie Nakamoto-Matsubara, MD, Koji Izutsu, Naoya Nakamura, MDPhD, Kengo Takeuchi, MD PhD, Seishi Ogawa, MD PhD, Shigeru Chiba, MD PhD

Blood (2014) 124 (21): 3025.

https://doi.org/10.1182/blood.V124.21.3025.3025

Published: 2014

Journal Articles

Is Radiation Therapy Effective for DLBCL As a Salvage after Chemotherapy?: A Study of 180 Diffuse Large B Cell Lymphoma (DLBCL) Cases at a Single Institution

Aya Ouchi, Yokoyama Masahiro, Masahiko Oguchi, MD, Kengo Takeuchi, MD PhD, Yoshiharu Kusano, MD, Hideaki Nitta, MD, Kyoko Ueda, MD, Noriko Nishimura, MD PhD, Naoko Tsuyama, MD, Yasuhito Terui, MD PhD, Noriko Usui, Keisuke Aiba, MD, PhD, Kiyohiko Hatake, MD PhD

Blood (2014) 124 (21): 5429.

https://doi.org/10.1182/blood.V124.21.5429.5429

Published: 2014

Journal Articles

ICE (Ifosfamide, carboplatin, and etoposide) Was the Best Salvage Regimen in Patients with Relapsed or Refractory Malignant Lymphoma

Yoshiharu Kusano, MD, Yasuhito Terui, MD PhD, Noriko Nishimura, MD PhD, Kyoko Ueda, MD, Gunji Tadahiro, MD, Hideaki Nitta, MD, Yuko Mishima, MD#12288;PhD, Masahiro Yokoyama, MD, Naoko Tsuyama, MD, Kengo Takeuchi, MD PhD, Kiyohiko Hatake, MD PhD

Blood (2014) 124 (21): 5432.

https://doi.org/10.1182/blood.V124.21.5432.5432

Published: 2014

Journal Articles

Pilot Study of Ruxolitinib in Relapsed or Refractory Hodgkin Lymphoma and Primary Mediastinal Large B-Cell Lymphoma

Seok Jin Kim, MD PhD, Hye Jin Kang, MD PhD, Dong-Yeop Shin, MD, Dok Hyun Yoon, Kana Sakamoto, MD, Jee Hyun Kong, MD, Young Hyeh Ko, MD PhD, Kengo Takeuchi, MD PhD, Cheolwon Suh, MD, PhD, Won Seog Kim, MD PhD

Blood (2014) 124 (21): 4443.

https://doi.org/10.1182/blood.V124.21.4443.4443

Published: 2014

Journal Articles

RT-DeVIC Therapy Is Effective for Localized NK/T Cell Lymphoma Patiens

Kyoko Ueda, MD, Noriko Nishimura, MD PhD, Yuko Mishima, MD PhD, Hideaki Nitta, MD, Yoshiharu Kusano, MD, Masahiro Yokoyama, MD, Naoko Tsuyama, Yasuhito Terui, MD PhD, Kengo Takeuchi, MD PhD, Oguchi Masahiko, MD PhD, Kiyohiko Hatake, MD PhD

Blood (2014) 124 (21): 1702.

https://doi.org/10.1182/blood.V124.21.1702.1702

Published: 2014

Journal Articles

High Thymidine Kinase Activity and CD5 Positivity Predict Poor Prognosis Of DLBCL Treated With R-CHOP

Kazuhito Suzuki, M.D., Yasuhito Terui, M.D., Ph D, Masahiro Yokoyama, MD, Noriko Nishimura, M.D., Ph D, Naoko Tsuyama, M.D., Kengo Takeuchi, MD, PhD, Noriko Usui, M.D., Ph D, Keisuke Aiba, M.D., Ph D, Kiyohiko Hatake, M.D., Ph D

Blood (2013) 122 (21): 5075.

https://doi.org/10.1182/blood.V122.21.5075.5075

Published: 2013

NARROW

The Prognostic Significance of Soluble Interleukin-2-Receptor, Beta-2-Microgrobulin and Serum Albumin in Patient with Diffuse Large B-Cell Lymphoma in the Rituximab Era

Efficacy of Rituximab Maintenance for Diffuse Large B Cell Lymphoma with Transformation

Impact of Creatinine Clearance in Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP : A Real-World Long-Term Observation Analysis at a Single Institute

B-Symptoms, Performance Status and Response to First Therapy As Survival Predictive Factors for Peripheral T-Cell Lymphoma at Progression/Relapse: A Single Institute Analysis

The Prognosis of Transformed DLBCL Were Superior to De Novo DLBL after the Relapsed/Refractory Status Related to the MYC Translocation

The Role of Image Surveillance in Patients with Diffuse Large B-Cell Lymphoma: A Single-Center Validation Study

Structural Variations Involving Programmed Death Ligands in B-Cell and T-Cell Lymphomas

Absolute CD4+ T-Cell Count Predicts Survival in Diffuse Large B-Cell Lymphoma

The Relapsed - Memorial Sloan - Kettering Cancer Center (R-MSKCC) Prognostic Score Is a Risk-Stratification Model for the Central Nervous System (CNS) Involvement at Relapse in Patients with Diffuse Large B Cell Lymphoma (DLBCL) in the Rituximab Era

The Efficacy of JAK2 Inhibitor in Heavily Pretreated Classical Hodgkin Lymphoma: A Prospective Pilot Study of Ruxolitinib in Relapsed or Refractory Classical Hodgkin Lymphoma and Primary Mediastinal Large B-Cell Lymphoma

80% Dose R-CHOP Is Suitable Chemotherapy for Very Elderly Patients with DLBCL

Higher Titer of Anti-EBV Nuclear Antigen Antibodies Might be a Marker of Poorer Prognosis in Patients with Peripheral T-Cell Lymphoma, Not Otherwise Specified

The Presence of M Protein Is Strongly Associated with Very Poor Prognosis in Patients with Extranodal Diffuse Large B-Cell Lymphoma

Identification of Cell-Type-Specific Mutations in Angioimmunoblastic T-Cell Lymphoma

Is Radiation Therapy Effective for DLBCL As a Salvage after Chemotherapy?: A Study of 180 Diffuse Large B Cell Lymphoma (DLBCL) Cases at a Single Institution

ICE (Ifosfamide, carboplatin, and etoposide) Was the Best Salvage Regimen in Patients with Relapsed or Refractory Malignant Lymphoma

Pilot Study of Ruxolitinib in Relapsed or Refractory Hodgkin Lymphoma and Primary Mediastinal Large B-Cell Lymphoma

RT-DeVIC Therapy Is Effective for Localized NK/T Cell Lymphoma Patiens

High Thymidine Kinase Activity and CD5 Positivity Predict Poor Prognosis Of DLBCL Treated With R-CHOP

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only